What is the current Vesical Catheters market size?

The Vesical Catheters market size was valued at USD 1.2 billion in 2023, driven by demand for urological care and procedural advancements.

What is the expected growth rate for Vesical Catheters?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and rising chronic disease prevalence.

What are the key drivers of Vesical Catheters demand?

Key drivers include increased urological procedures, geriatric population growth, and rising adoption of minimally invasive surgeries.

What challenges face the Vesical Catheters market?

Challenges include regulatory hurdles, product recalls due to contamination risks, and environmental concerns over disposable waste.

Which regions are leading the Vesical Catheters market?

North America and Europe dominate, while Asia-Pacific shows high growth due to expanding healthcare infrastructure and aging demographics.

Who are the top Vesical Catheters manufacturers?

Leading companies include B. Braun, Medtronic, Coloplast, Teleflex, and Smiths Medical, leveraging innovation and strategic partnerships.

What future opportunities exist in Vesical Catheters?

Opportunities lie in emerging markets, smart catheter technologies, and antimicrobial coatings to reduce infection risks.

How is technology impacting Vesical Catheters?

Advancements in IoT-enabled devices, biodegradable materials, and real-time monitoring systems are enhancing patient outcomes and adoption.

What regulatory issues affect Vesical Catheters?

Strict FDA and EMA guidelines for safety and efficacy, alongside evolving reimbursement policies, significantly influence market dynamics.

How Big Is the Vesical Catheters Market? Size, Share & Forecast 2033

Vesical Catheters by Application (Benign Prostate Hyperplasia, Urinary Incontinence, Others), by Types (Intermittent Catheter, External Catheters, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Vesical Catheters Market Size | CAGR 4.8 Forecast 2033

How Big Is the Vesical Catheters Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Vesical Catheters Market Overview

The Vesical Catheters market encompasses medical devices used for urinary drainage, critical in both hospital and home care settings. As a cornerstone of urological treatment, this market is driven by rising prevalence of urinary tract diseases and aging demographics. The Vesical Catheters market size is projected to exceed $1.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 6.5% from 2026–2033. Key growth outlook factors include advancements in antimicrobial-coated catheters and rising adoption of smart catheter systems for infection monitoring. The market forecast underscores industry expansion in Asia-Pacific, fueled by healthcare infrastructure modernization and government-funded dialysis programs.

Loading chart…

The segment-stacked chart illustrates the dominance of indwelling catheters (47% of total market share in 2026), driven by their use in surgical procedures and long-term care. Intermittent catheters (32%) are gaining traction due to their role in reducing hospital-acquired infections, while external catheters (21%) benefit from minimally invasive surgical adoption. Regulatory tailwinds, including FDA approvals for antimicrobial coatings, and supply-chain shifts toward low-cost manufacturing hubs in India and China are pivotal. North America remains the largest regional market, but Asia-Pacific is poised to outpace others due to unmet medical device demand and rapid urbanization.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.75 billion
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	A.M. Bickford; Amecath; Andromeda; Asid Bonz; Bard Medical; Biomatrix; Coloplast; CooperSurgical; Degania Silicone; Flexicare Medical; Jorgensen Laboratories; LABORIE; Mediplus; Mednova Medical Technology; Pacific Hospital Supply; PLASTI LAB; Poiesis Medical; Romed Holland; Shandong Steve Medical Science & Technology; Smiths Medical Surgivet; UROMED; Urotech; Vogt Medical; Vygon; Vygon Vet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of urological disorders such as benign prostatic hyperplasia and urinary incontinence is accelerating the Vesical Catheters market size. Aging populations and sedentary lifestyles are driving demand for both short-term and indwelling catheters globally.

Technological innovations in antimicrobial coatings and smart catheter sensors are enhancing patient outcomes. These advancements reduce infection risks and improve comfort, fueling adoption across hospitals and long-term care facilities.

Restraints2 items

High costs of advanced catheter solutions, such as self-expanding urethral catheters, may limit accessibility in low- and middle-income countries. Cost-sensitive healthcare systems often prioritize conventional products, curbing broader adoption.

Stringent regulatory frameworks in developed markets, including the EU’s MDR and FDA 510(k) requirements, are delaying product approvals and increasing R&D expenditures for manufacturers.

Opportunities2 items

Expansion into emerging markets presents significant growth potential. Rising healthcare investments in Asia-Pacific and Latin America, coupled with improving urology care infrastructure, are unlocking new revenue streams.

The shift toward home healthcare and ambulatory care settings is driving demand for user-friendly, disposable vesical catheters. Telemedicine integration further supports this trend, aligning with post-pandemic healthcare preferences.

Challenges2 items

Resistance to adopting novel catheter technologies due to entrenched clinical preferences and lack of training among healthcare providers remains a barrier. Overcoming this requires robust education and demonstration of cost-effectiveness.

Supply chain vulnerabilities, including raw material shortages and geopolitical tensions, are increasing production costs and causing delays in meeting the Vesical Catheters market growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Vesical Catheters market is driven by clinical needs across distinct therapeutic areas. Urological disorders, such as benign prostatic hyperplasia (BPH) and urinary tract infections (UTIs), dominate this segment, accounting for approximately 45% of global demand due to their high prevalence and chronic nature. Post-surgical management, particularly after urological or gynecological procedures, represents a 30% share, reflecting the critical role of catheters in post-operative recovery. Geriatric care, addressing age-related conditions like neurogenic bladder and incontinence, contributes 25%, underscoring the aging population’s impact on market growth. These subcategories collectively define the Vesical Catheters segmentation, shaping demand patterns through disease burden, procedural adoption, and demographic shifts.

The Types segment is categorized into Indwelling and Intermittent catheters. Indwelling catheters, retained in the bladder for extended periods, hold a 60% market share, driven by hospitalization rates and chronic care requirements. Their usage in ICU settings and for immobilized patients ensures steady demand despite infection risks. Intermittent catheters, used for short-term or periodic voiding, capture 40% of the market, favored by patients with neurogenic bladder or those avoiding long-term catheterization. This duality in market taxonomy reflects clinical preference balances between patient comfort, infection control, and cost-effectiveness, with regulatory trends favoring intermittent options for home care scenarios.

Vesical Catheters Segmentation Breakdown8 items

Application

Benign Prostate Hyperplasia

Urinary Incontinence

Others

Types

Intermittent Catheter

External Catheters

Others

Regional Insights

Loading chart…

North America leads the Vesical Catheters market with a 40% share, driven by advanced healthcare infrastructure, high adoption of urological devices, and robust R&D investments. The region’s aging population and rising prevalence of urinary tract disorders further propel demand. Europe follows with a 30% share, supported by stringent regulatory frameworks, growing geriatric demographics, and strong public healthcare policies. Asia Pacific is the fastest-growing region, expanding at a CAGR of 8%, fueled by urbanization, rising disposable incomes, and government initiatives to modernize healthcare. Latin America accounts for 5%, with growth linked to improving medical infrastructure and increasing awareness of minimally invasive treatments. The Middle East & Africa segment contributes 5%, driven by urbanization and rising investments in healthcare facilities, though challenges in infrastructure and affordability persist.

The Vesical Catheters market growth is most pronounced in Asia Pacific, where ecosystem maturity and policy reforms are accelerating digital health integration. In North America and Europe, maturity in the market is offset by innovation in smart catheter technologies and reimbursement reforms. Regional forecast models highlight Asia Pacific’s potential to surpass Europe in market share by 2030, while Latin America and the Middle East & Africa remain underpenetrated but strategically important for long-term expansion.

Competitive Landscape

The Vesical Catheters market exhibits a moderately consolidated structure, with a mix of global players and regional manufacturers. Key players leverage differentiated strategies across pricing tiers, regulatory compliance, and product innovation to capture market segments. Competitive dynamics are shaped by Vesical Catheters key players prioritizing FDA/EU certification as a barrier to entry, while cost optimization pressures drive localization of production. Global firms dominate high-end specialty catheters, whereas regional suppliers focus on price-sensitive markets, creating dual tracks of competition. Product differentiation remains critical, with emphasis on material innovation (e.g., silicone, hydrophilic coatings) and ergonomic design to address patient comfort and infection control.

Strategic priorities include M&A to consolidate regional footprints, partnerships with OEMs for niche product lines, and R&D investments for smart catheter technologies. Competitive differentiation hinges on technology (e.g., antimicrobial coatings), channel strength in hospital vs. home care settings, and customization for urological subspecialties. A persistent challenge is margin compression due to commoditization in standard urinary catheters, forcing firms to balance cost structures with premium product launches. Localization strategies and vertical integration are increasingly adopted to mitigate supply chain volatility and regulatory delays.

Coloplast: innovation pipeline in antimicrobial catheters

Bard Medical: OEM tie-ups for urology specialty lines

CooperSurgical: regional expansion in emerging markets

A.M. Bickford: cost advantages via local manufacturing

Mednova Medical Technology: vertical integration for supply chain control

Vygon: premium pricing for high-comfort hydrophilic products

Key Vesical Catheters Companies25 items

A.M. Bickford

Amecath

Andromeda

Asid Bonz

Bard Medical

Biomatrix

Coloplast

CooperSurgical

Degania Silicone

Flexicare Medical

Jorgensen Laboratories

LABORIE

Mediplus

Mednova Medical Technology

Pacific Hospital Supply

PLASTI LAB

Poiesis Medical

Romed Holland

Shandong Steve Medical Science & Technology

Smiths Medical Surgivet

UROMED

Urotech

Vogt Medical

Vygon

Vygon Vet

Market Ecosystem

The Vesical Catheters ecosystem spans upstream raw material suppliers, midstream manufacturers and technology integrators, and downstream healthcare providers. Value creation begins with component sourcing and manufacturing, followed by distribution and end-user application. Regulatory compliance and clinical validation are critical to capturing value across the value chain analysis.

Raw material/component suppliers — provide polymers, coatings, and biocompatible materials for catheter production

OEMs / manufacturers — design, produce, and quality-test vesical catheters to medical standards

Technology providers — supply specialized components like sensors or antimicrobial treatments

Distributors / channel partners — manage regional logistics, inventory, and B2B/B2C delivery to healthcare facilities

Service providers / after-sales — offer sterilization, maintenance, and training for catheter usage and disposal

Regulators/standards bodies — enforce compliance with FDA, ISO, and CE certification requirements

End users / buyers — include hospitals, urology clinics, and home healthcare providers utilizing catheters

Control points reside with regulators, whose approvals dictate market entry, and OEMs, whose proprietary technology shapes product differentiation. Dependency risks include material shortages, regulatory delays, and interoperability constraints with hospital systems. End-user switching costs are moderate due to certification requirements and established supplier partnerships, while regional disparities in healthcare infrastructure further fragment the ecosystem.

Recent Industry Insights

The Vesical Catheters industry trends over the past 18 months reflect a surge in innovation and strategic consolidation. Partnerships have expanded as companies like Teleflex and Medtronic collaborate with urology clinics to integrate antimicrobial coatings into catheter designs, reducing infection risks. Mergers & acquisitions accelerated, with B. Braun acquiring a specialized hydrophilic catheter firm to strengthen its market position. Product launches highlight advancements in smart catheters, such as Bard’s sensor-equipped devices for real-time bladder monitoring. Regulatory changes, including the EU’s Medical Device Regulation (MDR) enforcement, have driven stricter compliance and quality standards across the sector. Consumer trends show a growing preference for home healthcare, boosting demand for self-catheterization kits with user-friendly designs. Funding rounds indicate strong investor interest, with startups like UroTech securing $20M to develop biodegradable catheter materials. These developments underscore a market prioritizing patient safety, technological integration, and sustainable solutions.

Analyst Overview

The Vesical Catheters market outlook remains robust, driven by an aging global population, rising prevalence of urological disorders, and expanding healthcare infrastructure in emerging economies. Market attractiveness is elevated by unmet clinical needs and opportunities for innovation, particularly in infection prevention and patient comfort. However, regulatory scrutiny and pricing pressures in mature markets temper growth potential.

Key Insights5 items

Competitive intensity is moderate, with established players dominating through R&D and strategic acquisitions, while niche innovators target specialized segments like antimicrobial or smart catheters.

Long-term outlook favors sustained growth through 2030, supported by demographic trends and technological adoption, though reimbursement challenges in emerging markets may slow penetration.

Innovation landscape highlights advancements in biocompatible materials, antimicrobial coatings, and IoT-enabled devices to enhance patient outcomes and reduce complications.

Demand–supply balance remains stable, but raw material volatility and logistical constraints in low-income regions pose intermittent risks to supply chain resilience.

Key risk factors include stringent regulatory compliance, litigation over product safety, and potential shifts in reimbursement policies impacting market access.

12 items

1. Executive Summary

2. Vesical Catheters Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Vesical Catheters Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Vesical Catheters Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Vesical Catheters Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Vesical Catheters Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Vesical Catheters Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Vesical Catheters Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Vesical Catheters Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Vesical Catheters Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Vesical Catheters Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Vesical Catheters Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Vesical Catheters Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Vesical Catheters Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Vesical Catheters Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Vesical Catheters Market Competition by Key Manufacturers

9.1. Global Vesical Catheters Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Vesical Catheters: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. A.M. Bickford

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Amecath

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Andromeda

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Asid Bonz

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bard Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Biomatrix

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Coloplast

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. CooperSurgical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Degania Silicone

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Flexicare Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jorgensen Laboratories

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. LABORIE

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Mediplus

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Mednova Medical Technology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Pacific Hospital Supply

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. PLASTI LAB

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Poiesis Medical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Romed Holland

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Shandong Steve Medical Science & Technology

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Smiths Medical Surgivet

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. UROMED

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Urotech

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Vogt Medical

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Vygon

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Vygon Vet

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Vesical Catheters Market

Figure 4: Global Vesical Catheters Market: Drivers

Figure 5: Global Vesical Catheters Market: Challenges

Figure 6: Global Vesical Catheters Market: Trends

Figure 7: Global Vesical Catheters Market: Opportunity

Figure 8: Global Vesical Catheters Market: Restraint

Figure 9: Global Vesical Catheters Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Vesical Catheters Market Value (USD Million) By Region

Figure 19: Global Vesical Catheters Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Vesical Catheters Market Value (USD Million) By Region

Figure 27: Global Vesical Catheters Market Share (%) By: Regions (2032)

Figure 28: Global Vesical Catheters Market Volume (K) By Region

Figure 29: Global Vesical Catheters Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Vesical Catheters Market Value (USD Million) By Region

Figure 37: Global Vesical Catheters Market Share (%) By: Regions (2032)

Figure 38: Global Vesical Catheters Market Volume (K) By Region

Figure 39: Global Vesical Catheters Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

145 items

Table 1: Market Segmentation Analysis

Table 2: Global Vesical Catheters Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Vesical Catheters Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Vesical Catheters Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Vesical Catheters Market Value (USD Million) By Region

Table 14: Global Vesical Catheters Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Vesical Catheters Market Volume (K) By Region

Table 31: Global Vesical Catheters Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Vesical Catheters Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Vesical Catheters Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Vesical Catheters Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: A.M. Bickford Basic Information And Sales Area

Table 52: A.M. Bickford. Products Portfolio

Table 53: Amecath Basic Information And Sales Area

Table 54: Amecath. Products Portfolio

Table 55: Andromeda Basic Information And Sales Area

Table 56: Andromeda. Products Portfolio

Table 57: Asid Bonz Basic Information And Sales Area

Table 58: Asid Bonz. Products Portfolio

Table 59: Bard Medical Basic Information And Sales Area

Table 60: Bard Medical. Products Portfolio

Table 61: Biomatrix Basic Information And Sales Area

Table 62: Biomatrix. Products Portfolio

Table 63: Coloplast Basic Information And Sales Area

Table 64: Coloplast. Products Portfolio

Table 65: CooperSurgical Basic Information And Sales Area

Table 66: CooperSurgical. Products Portfolio

Table 67: Degania Silicone Basic Information And Sales Area

Table 68: Degania Silicone. Products Portfolio

Table 69: Flexicare Medical Basic Information And Sales Area

Table 70: Flexicare Medical. Products Portfolio

Table 71: Jorgensen Laboratories Basic Information And Sales Area

Table 72: Jorgensen Laboratories. Products Portfolio

Table 73: LABORIE Basic Information And Sales Area

Table 74: LABORIE. Products Portfolio

Table 75: Mediplus Basic Information And Sales Area

Table 76: Mediplus. Products Portfolio

Table 77: Mednova Medical Technology Basic Information And Sales Area

Table 78: Mednova Medical Technology. Products Portfolio

Table 79: Pacific Hospital Supply Basic Information And Sales Area

Table 80: Pacific Hospital Supply. Products Portfolio

Table 81: PLASTI LAB Basic Information And Sales Area

Table 82: PLASTI LAB. Products Portfolio

Table 83: Poiesis Medical Basic Information And Sales Area

Table 84: Poiesis Medical. Products Portfolio

Table 85: Romed Holland Basic Information And Sales Area

Table 86: Romed Holland. Products Portfolio

Table 87: Shandong Steve Medical Science & Technology Basic Information And Sales Area

Table 88: Shandong Steve Medical Science & Technology. Products Portfolio

Table 89: Smiths Medical Surgivet Basic Information And Sales Area

Table 90: Smiths Medical Surgivet. Products Portfolio

Table 91: UROMED Basic Information And Sales Area

Table 92: UROMED. Products Portfolio

Table 93: Urotech Basic Information And Sales Area

Table 94: Urotech. Products Portfolio

Table 95: Vogt Medical Basic Information And Sales Area

Table 96: Vogt Medical. Products Portfolio

Table 97: Vygon Basic Information And Sales Area

Table 98: Vygon. Products Portfolio

Table 99: Vygon Vet Basic Information And Sales Area

Table 100: Vygon Vet. Products Portfolio

Table 101: Global Market Value (USD Million) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Value (USD Million) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global Market Volume (K) (2025-2032) By Application

Table 106: Global Market Share (%) By Application (2032)

Table 107: Global Market Volume (K) (2025-2032) By Types

Table 108: Global Market Share (%) By Types (2032)

Table 109: Global Vesical Catheters Market Value (USD Million) By Region

Table 110: Global Vesical Catheters Market Share (%) By Region (2025-2032)

Table 111: North America Market Value (USD Million) (2025-2032) By Country

Table 112: North America Market Value (USD Million) (2025-2032) By Application

Table 113: North America Market Value (USD Million) (2025-2032) By Types

Table 114: Europe Market Value (USD Million) (2025-2032) By Country

Table 115: Europe Market Value (USD Million) (2025-2032) By Application

Table 116: Europe Market Value (USD Million) (2025-2032) By Types

Table 117: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 118: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 119: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 120: South America Market Value (USD Million) (2025-2032) By Country

Table 121: South America Market Value (USD Million) (2025-2032) By Application

Table 122: South America Market Value (USD Million) (2025-2032) By Types

Table 123: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 124: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 125: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 126: Global Vesical Catheters Market Volume (K) By Region

Table 127: Global Vesical Catheters Market Share (%) By Region (2025-2032)

Table 128: North America Market Volume (K) (2025-2032) By Country

Table 129: North America Market Volume (K) (2025-2032) By Application

Table 130: North America Market Volume (K) (2025-2032) By Types

Table 131: Europe Market Volume (K) (2025-2032) By Country

Table 132: Europe Market Volume (K) (2025-2032) By Application

Table 133: Europe Market Volume (K) (2025-2032) By Types

Table 134: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 135: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 136: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 137: South America Market Volume (K) (2025-2032) By Country

Table 138: South America Market Volume (K) (2025-2032) By Application

Table 139: South America Market Volume (K) (2025-2032) By Types

Table 140: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 141: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 142: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 143: Research Programs/Design For This Report

Table 144: Key Data Information From Secondary Sources

Table 145: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Vesical Catheters Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.75 billion
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	A.M. Bickford; Amecath; Andromeda; Asid Bonz; Bard Medical; Biomatrix; Coloplast; CooperSurgical; Degania Silicone; Flexicare Medical; Jorgensen Laboratories; LABORIE; Mediplus; Mednova Medical Technology; Pacific Hospital Supply; PLASTI LAB; Poiesis Medical; Romed Holland; Shandong Steve Medical Science & Technology; Smiths Medical Surgivet; UROMED; Urotech; Vogt Medical; Vygon; Vygon Vet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options